-
Je něco špatně v tomto záznamu ?
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
IE. Lundberg, A. Tjärnlund, M. Bottai, VP. Werth, C. Pilkington, M. de Visser, L. Alfredsson, AA. Amato, RJ. Barohn, MH. Liang, JA. Singh, R. Aggarwal, S. Arnardottir, H. Chinoy, RG. Cooper, K. Dankó, MM. Dimachkie, BM. Feldman, I. Garcia-De La...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Intramural, práce podpořená grantem
PubMed
29106061
DOI
10.1002/art.40320
Knihovny.cz E-zdroje
- MeSH
- biopsie normy MeSH
- dítě MeSH
- dospělí MeSH
- konsensus MeSH
- kosterní svaly patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- myozitida klasifikace diagnóza MeSH
- revmatologie normy MeSH
- senzitivita a specificita MeSH
- směrnice pro lékařskou praxi jako téma * MeSH
- společnosti lékařské MeSH
- určení symptomu metody normy MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Intramural MeSH
- Geografické názvy
- Evropa MeSH
- Spojené státy americké MeSH
OBJECTIVE: To develop and validate new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIM) and their major subgroups. METHODS: Candidate variables were assembled from published criteria and expert opinion using consensus methodology. Data were collected from 47 rheumatology, dermatology, neurology, and pediatric clinics worldwide. Several statistical methods were utilized to derive the classification criteria. RESULTS: Based on data from 976 IIM patients (74% adults; 26% children) and 624 non-IIM patients with mimicking conditions (82% adults; 18% children), new criteria were derived. Each item is assigned a weighted score. The total score corresponds to a probability of having IIM. Subclassification is performed using a classification tree. A probability cutoff of 55%, corresponding to a score of 5.5 (6.7 with muscle biopsy) "probable IIM," had best sensitivity/specificity (87%/82% without biopsies, 93%/88% with biopsies) and is recommended as a minimum to classify a patient as having IIM. A probability of ≥90%, corresponding to a score of ≥7.5 (≥8.7 with muscle biopsy), corresponds to "definite IIM." A probability of <50%, corresponding to a score of <5.3 (<6.5 with muscle biopsy), rules out IIM, leaving a probability of ≥50-<55% as "possible IIM." CONCLUSION: The European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for IIM have been endorsed by international rheumatology, dermatology, neurology, and pediatric groups. They employ easily accessible and operationally defined elements, and have been partially validated. They allow classification of "definite," "probable," and "possible" IIM, in addition to the major subgroups of IIM, including juvenile IIM. They generally perform better than existing criteria.
Academic Medical Centre Amsterdam The Netherlands
Brigham and Women's Hospital and Boston VA Healthcare Boston Massachusetts
Brigham and Women's Hospital Harvard Medical School Boston Massachusetts
Central Manchester University Hospitals NHS Foundation Trust University of Manchester Manchester UK
Charles University Prague Czech Republic
Duke University Durham North Carolina
Great Ormond Street Hospital for Children NHS Trust London UK
Hospital General de Occidente Secretaría de Salud and University of Guadalajara Guadalajara Mexico
Institute of Rheumatology Warsaw Poland
IWK Health Centre and Dalhousie University Halifax Nova Scotia Canada
Karolinska Institutet Stockholm Sweden
Karolinska University Hospital and Karolinska Institutet Stockholm Sweden
King's College Hospital NHS Foundation Trust London UK
Mayo Clinic College of Medicine Rochester Minnesota
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIH Bethesda Maryland
National Institute of Environmental Health Sciences NIH Bethesda Maryland
National Institute of Geriatrics Rheumatology and Rehabilitation Warsaw Poland
Oregon State University Corvallis
Oslo University Hospital Rikshospitalet Oslo Norway
People's Hospital of Beijing University Beijing China
Philadelphia VA Medical Center and Hospital of the University of Pennsylvania Philadelphia
Seoul National University College of Medicine Seoul Republic of Korea
Tokyo Medical and Dental University Tokyo Japan
University of Debrecen Debrecen Hungary
University of Kansas Medical Center Kansas City
University of Liverpool Liverpool UK
University of Pittsburgh School of Medicine Pittsburgh Pennsylvania
University of Toronto and The Hospital for Sick Children Toronto Ontario Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016239
- 003
- CZ-PrNML
- 005
- 20180523132559.0
- 007
- ta
- 008
- 180515s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/art.40320 $2 doi
- 035 __
- $a (PubMed)29106061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Lundberg, Ingrid E $u Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
- 245 10
- $a 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups / $c IE. Lundberg, A. Tjärnlund, M. Bottai, VP. Werth, C. Pilkington, M. de Visser, L. Alfredsson, AA. Amato, RJ. Barohn, MH. Liang, JA. Singh, R. Aggarwal, S. Arnardottir, H. Chinoy, RG. Cooper, K. Dankó, MM. Dimachkie, BM. Feldman, I. Garcia-De La Torre, P. Gordon, T. Hayashi, JD. Katz, H. Kohsaka, PA. Lachenbruch, BA. Lang, Y. Li, CV. Oddis, M. Olesinska, AM. Reed, L. Rutkowska-Sak, H. Sanner, A. Selva-O'Callaghan, YW. Song, J. Vencovsky, SR. Ytterberg, FW. Miller, LG. Rider, . ,
- 520 9_
- $a OBJECTIVE: To develop and validate new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIM) and their major subgroups. METHODS: Candidate variables were assembled from published criteria and expert opinion using consensus methodology. Data were collected from 47 rheumatology, dermatology, neurology, and pediatric clinics worldwide. Several statistical methods were utilized to derive the classification criteria. RESULTS: Based on data from 976 IIM patients (74% adults; 26% children) and 624 non-IIM patients with mimicking conditions (82% adults; 18% children), new criteria were derived. Each item is assigned a weighted score. The total score corresponds to a probability of having IIM. Subclassification is performed using a classification tree. A probability cutoff of 55%, corresponding to a score of 5.5 (6.7 with muscle biopsy) "probable IIM," had best sensitivity/specificity (87%/82% without biopsies, 93%/88% with biopsies) and is recommended as a minimum to classify a patient as having IIM. A probability of ≥90%, corresponding to a score of ≥7.5 (≥8.7 with muscle biopsy), corresponds to "definite IIM." A probability of <50%, corresponding to a score of <5.3 (<6.5 with muscle biopsy), rules out IIM, leaving a probability of ≥50-<55% as "possible IIM." CONCLUSION: The European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for IIM have been endorsed by international rheumatology, dermatology, neurology, and pediatric groups. They employ easily accessible and operationally defined elements, and have been partially validated. They allow classification of "definite," "probable," and "possible" IIM, in addition to the major subgroups of IIM, including juvenile IIM. They generally perform better than existing criteria.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a biopsie $x normy $7 D001706
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a Evropa $7 D005060
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a kosterní svaly $x patologie $7 D018482
- 650 _2
- $a myozitida $x klasifikace $x diagnóza $7 D009220
- 650 12
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a revmatologie $x normy $7 D012219
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a společnosti lékařské $7 D012955
- 650 _2
- $a určení symptomu $x metody $x normy $7 D063189
- 650 _2
- $a Spojené státy americké $7 D014481
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Intramural $7 D052060
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tjärnlund, Anna $u Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Bottai, Matteo $u Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Werth, Victoria P $u Philadelphia VA Medical Center and Hospital of the University of Pennsylvania, Philadelphia.
- 700 1_
- $a Pilkington, Clarissa $u Great Ormond Street Hospital for Children NHS Trust, London, UK.
- 700 1_
- $a de Visser, Marianne $u Academic Medical Centre, Amsterdam, The Netherlands.
- 700 1_
- $a Alfredsson, Lars $u Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Amato, Anthony A $u Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- 700 1_
- $a Barohn, Richard J $u University of Kansas Medical Center, Kansas City.
- 700 1_
- $a Liang, Matthew H $u Brigham and Women's Hospital and Boston VA Healthcare, Boston, Massachusetts.
- 700 1_
- $a Singh, Jasvinder A $u Mayo Clinic College of Medicine, Rochester, Minnesota, and University of Alabama and Birmingham VA Medical Center, Birmingham, Alabama.
- 700 1_
- $a Aggarwal, Rohit $u University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- 700 1_
- $a Arnardottir, Snjolaug $u Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Chinoy, Hector $u Central Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, UK.
- 700 1_
- $a Cooper, Robert G $u University of Liverpool, Liverpool, UK.
- 700 1_
- $a Dankó, Katalin $u University of Debrecen, Debrecen, Hungary.
- 700 1_
- $a Dimachkie, Mazen M $u University of Kansas Medical Center, Kansas City.
- 700 1_
- $a Feldman, Brian M $u University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada.
- 700 1_
- $a Garcia-De La Torre, Ignacio $u Hospital General de Occidente, Secretaría de Salud and University of Guadalajara, Guadalajara, Mexico.
- 700 1_
- $a Gordon, Patrick $u King's College Hospital NHS Foundation Trust, London, UK.
- 700 1_
- $a Hayashi, Taichi $u University of Tsukuba, Tsukuba, Japan.
- 700 1_
- $a Katz, James D $u National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
- 700 1_
- $a Kohsaka, Hitoshi $u Tokyo Medical and Dental University, Tokyo, Japan.
- 700 1_
- $a Lachenbruch, Peter A $u Oregon State University, Corvallis.
- 700 1_
- $a Lang, Bianca A $u IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
- 700 1_
- $a Li, Yuhui $u People's Hospital of Beijing University, Beijing, China.
- 700 1_
- $a Oddis, Chester V $u University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- 700 1_
- $a Olesinska, Marzena $u National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
- 700 1_
- $a Reed, Ann M $u Duke University, Durham, North Carolina.
- 700 1_
- $a Rutkowska-Sak, Lidia $u Institute of Rheumatology, Warsaw, Poland.
- 700 1_
- $a Sanner, Helga $u Oslo University Hospital-Rikshospitalet, Oslo, Norway.
- 700 1_
- $a Selva-O'Callaghan, Albert $u Vall d'Hebron General Hospital, Barcelona, Spain.
- 700 1_
- $a Song, Yeong-Wook $u Seoul National University College of Medicine, Seoul, Republic of Korea.
- 700 1_
- $a Vencovsky, Jiri $u Charles University, Prague, Czech Republic.
- 700 1_
- $a Ytterberg, Steven R $u Mayo Clinic College of Medicine, Rochester, Minnesota.
- 700 1_
- $a Miller, Frederick W $u National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.
- 700 1_
- $a Rider, Lisa G $u National Institute of Environmental Health Sciences, NIH, Bethesda, Maryland.
- 700 1_
- $a ,
- 773 0_
- $w MED00188151 $x 2326-5205 $g Roč. 69, č. 12 (2017), s. 2271-2282 $t Arthritis & rheumatology (Hoboken, N.J.)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29106061 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180523132743 $b ABA008
- 999 __
- $a ok $b bmc $g 1299863 $s 1013079
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 69 $c 12 $d 2271-2282 $e 20171027 $i 2326-5205 $m Arthritis & rheumatology $x MED00188151
- LZP __
- $a Pubmed-20180515